AV junction ablation in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy: The picture is now clear!

Journal of the American College of Cardiology

Volumn 59, Issue 8, 2012, Pages 727-729

  Gasparini, Maurizio ^a   Galimberti, Paola ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

atrial fibrillation; biventricular pacing; cardiac resynchronization; heart failure

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN;

CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; DISEASE CLASSIFICATION; HEART ATRIOVENTRICULAR JUNCTION ABLATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HUMAN; MORBIDITY; MORTALITY; NOTE; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINUS RHYTHM; SURVIVAL RATE; TREATMENT INDICATION;

EID: 84856884189     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.08.081     Document Type: Editorial

References (10)

1. K. Dickstein, P.E. Vardas, A. Auricchio 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Europace 12 2010 1526 1536
2. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Circulation 117 2008 e350 e408
3. A.N. Ganesan, A.G. Brooks, K.C. Roberts-Thomson, D.H. Lau, J.M. Kalman, P. Sanders Role of AV nodal ablation in cardiac resynchronization therapy in patients with coexistent atrial fibrillation and heart failure: a systematic review J Am Coll Cardiol 59 2012 719 726
4. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
5. S.G. Molhoek, J.J. Bax, J.B. Bleeker Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation Am J Cardiol 94 2004 1506 1509 (Pubitemid 40268451)
6. K. Dong, W.K. Shen, B.D. Powell Atrioventricular nodal ablation predicts survival benefits in patients with atrial fibrillation receiving cardiac resynchronization therapy Heart Rhythm 7 2010 1240 1245
7. M. Gasparini, A. Auricchio, F. Regoli Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation J Am Coll Cardiol 48 2006 734 743 (Pubitemid 44175735)
8. M. Gasparini, A. Cappelleri Atrial arrhythmias after cardiac resynchronization therapy: an inverse correlation with achieving 100% biventricular pacing and cardiac resynchronization therapy effectiveness Europace 12 2010 9 10
9. M. Gasparini, J.S. Steinberg, A. Arshad Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study Eur Heart J 31 2010 976 983
10. D.L. Hayes, J.P. Boehmer, J.D. Day Cardiac resynchronization therapy and relationship of percent biventricular pacing to symptoms and survival Heart Rhythm 8 2011 1469 1475